Your browser doesn't support javascript.
loading
Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis.
Ljung, Lotta; Jönsson, Elias; Franklin, Johan; Berglin, Ewa; Lundquist, Anders; Rantapää-Dahlqvist, Solbritt.
Afiliación
  • Ljung L; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå Sweden; Academic Specialist Center, Center for Rheumatology, Health Care Services Stockholm County (SLSO), Stockholm, Sweden.
  • Jönsson E; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå Sweden.
  • Franklin J; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå Sweden.
  • Berglin E; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå Sweden.
  • Lundquist A; Department of Statistics, USBE, Umeå University, Umeå, Sweden.
  • Rantapää-Dahlqvist S; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå Sweden. Electronic address: solbritt.rantapaa.dahlqvist@umu.se.
Eur J Intern Med ; 2024 May 04.
Article en En | MEDLINE | ID: mdl-38705755
ABSTRACT

OBJECTIVE:

Rheumatoid arthritis [RA) is a chronic inflammatory disease, with potential for extra-articular manifestations (ExRA). The incidence and predisposing factors for ExRA and the mortality were evaluated in an early RA inception cohort.

METHODS:

Patients (n = 1468; 69 % females, mean age (SD) 57.3(16.3) years) were consecutively included at the date of diagnosis, between 1 January 1996 and 31 December 2016, and assessed prospectively. In December 2016 development of ExRA was evaluated by a patient questionnaire and a review of medical records. Cumulative incidence and incidence rates were compared between 5-year periods and between patients included before and after 1 January 2001. Cox proportional hazard regression models were used to identify predictors for ExRA, and models with ExRA as time-dependent variables to estimate the mortality.

RESULTS:

After a mean (SD) follow-up of 9.3(4.9) years, 238 cases (23.3 %) had ExRA and 151 (14.7 %) had ExRA without rheumatoid nodules. Most ExRA developed within 5 years from diagnosis. Rheumatoid nodules (10.5 %) and keratoconjunctivitis sicca (7.1 %) were the most frequent manifestations, followed by pulmonary fibrosis (6.1 %). The ExRA incidence among more recently diagnosed patients was similar as to the incidence among patients diagnosed before 2001. Seropositivity, smoking and early biological treatment were associated with development of ExRA. After 15 years 20 % had experienced ExRA. ExRA was associated with increased mortality, HR 3.029 (95 % CI 2.177-4.213).

CONCLUSIONS:

Early development of ExRA is frequent, particularly rheumatoid nodules. Predisposing factors were age, RF positivity, smoking and early biological treatment. The patients with ExRA had a 3-fold increase in mortality.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article